Director, US Health Economic Value Access (HEVA)

Iovance Biotherapeutics(11 days ago)

RemoteFull TimeSenior$230,000 - $260,000Market Access

About this role

The role focuses on developing health economic evidence, formulating value-based messaging, and creating pricing strategies for cell and gene therapies in the US market. It involves collaboration with cross-functional teams, stakeholder engagement, and supporting market access initiatives for innovative therapies.

View Original Listing

Required Skills

Health Economics
Market Access
Cost Effectiveness
HEOR
Pricing Strategy
Formulary Management
Economic Modeling
Stakeholder Engagement
Pharmacoeconomics
Data Analysis

Qualifications

Advanced Degree in Health Economics, Public Health, Economics, or related field

About Iovance Biotherapeutics

iovance.com

Iovance Biotherapeutics is a clinical-stage biopharmaceutical company developing tumor-infiltrating lymphocyte (TIL) therapies that harness a patient’s own immune cells to recognize and kill diverse cancer cells. Its lead product, AMTAGVI (lifileucel), has received U.S. FDA accelerated approval for defined indications, and the company is advancing multiple clinical trials across solid tumors. Iovance builds and operates cell therapy manufacturing and Iovance Cell Therapy Centers to support production and commercialization, and partners with academic and industry collaborators to advance next‑generation T‑cell platforms. The company also provides patient resources, an expanded-access policy, and information about its pipeline and research.

View more jobs at Iovance Biotherapeutics →